Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)

Jiangsu Yahong Meditech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	351.15	779.45	628.2	1,738	1,035	2,613
Short-Term Investments	-	161.24	150.54	14.54	-	-
Trading Asset Securities	832.02	668	657.21	594.31	1,703	369.77
Cash & Short-Term Investments	1,183	1,609	1,436	2,347	2,738	2,983
Cash Growth	-31.66%	12.03%	-38.82%	-14.29%	-8.20%	273.49%
Accounts Receivable	142.3	98.56	59.9	8.68	0.02	0
Other Receivables	6.5	6.46	11.63	5.9	3.04	2.07
Receivables	148.8	105.02	71.53	14.57	3.06	2.08
Inventory	25.01	21.92	5.84	1.61	2.79	3.81
Other Current Assets	218.79	26.12	17.63	12.2	15.93	19.79
Total Current Assets	1,576	1,762	1,531	2,375	2,760	3,009
Property, Plant & Equipment	60.35	73.49	85.45	88.5	36.8	26.88
Long-Term Investments	16.16	99.85	474.22	26.41	15.34	-
Other Intangible Assets	109.03	73.68	53.98	61.39	21.79	22.13
Long-Term Deferred Tax Assets	2.16	2.4	2.09	1.26	0.25	-
Long-Term Deferred Charges	5.06	4.5	5.96	9.86	12.13	7.79
Other Long-Term Assets	78.39	41.83	70.35	69.4	27.64	33.43
Total Assets	1,847	2,057	2,223	2,632	2,874	3,099

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	45.27	51.54	47.26	59.22	43.65	33.57
Accrued Expenses	32.85	80.56	55.32	38.42	24.64	32.92
Short-Term Debt	90.26	238.5	66.25	73.4	-	-
Current Portion of Long-Term Debt	-	1.3	-	-	-	-
Current Portion of Leases	-	17.91	14.34	10.29	7.37	5.66
Current Income Taxes Payable	-	-	0.31	0.34	1.52	-
Current Unearned Revenue	1.04	0.22	0.31	-	-	-
Other Current Liabilities	74.78	12.36	13.28	3.67	3.48	1.74
Total Current Liabilities	244.19	402.4	197.06	185.35	80.66	73.89
Long-Term Debt	205.21	48.44	-	-	-	-
Long-Term Leases	29.39	39	49.95	50.77	11.31	11.76
Long-Term Unearned Revenue	4.22	4.6	5.61	6.39	11	0.32
Long-Term Deferred Tax Liabilities	0	-	-	-	0	-
Other Long-Term Liabilities	30	-	-	-	-	-
Total Liabilities	513.01	494.44	252.62	242.5	102.98	85.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	572.19	571.17	570	570	570	570
Additional Paid-In Capital	2,908	2,907	2,884	2,863	2,848	2,841
Retained Earnings	-2,084	-1,845	-1,429	-1,045	-644.27	-397.92
Treasury Stock	-35.31	-50.06	-50.06	-	-	-
Comprehensive Income & Other	-7.33	-6.74	-5.54	-0.38	-2.44	-
Total Common Equity	1,354	1,576	1,969	2,388	2,771	3,013
Minority Interest	-19.98	-13.28	0.97	1.8	-	-
Shareholders' Equity	1,334	1,563	1,970	2,390	2,771	3,013
Total Liabilities & Equity	1,847	2,057	2,223	2,632	2,874	3,099

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	324.85	345.15	130.54	134.46	18.69	17.42
Net Cash (Debt)	858.32	1,264	1,305	2,213	2,720	2,966
Net Cash Growth	-41.78%	-3.21%	-41.00%	-18.64%	-8.29%	271.31%
Net Cash Per Share	1.51	2.25	2.31	3.70	4.74	6.44
Filing Date Shares Outstanding	574.22	562.5	561.33	570	570	570
Total Common Shares Outstanding	574.22	562.5	561.33	570	570	570
Working Capital	1,332	1,359	1,334	2,190	2,679	2,935
Book Value Per Share	2.36	2.80	3.51	4.19	4.86	5.29
Tangible Book Value	1,245	1,503	1,915	2,327	2,749	2,991
Tangible Book Value Per Share	2.17	2.67	3.41	4.08	4.82	5.25
Machinery	-	52.29	49.56	46.55	27.8	15.67

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error